Table 4.
YLD rank |
YLDs per 100 000 population (95% UI) |
Age-standardised percentage change in YLDs (95% UI) |
|||||||
---|---|---|---|---|---|---|---|---|---|
1990 | 2010 | 2019 | 1990 | 2010 | 2019 | 1990–2010 | 2010–19 | 1990–2019 | |
Lower back pain | 1 | 1 | 1 | 1115·3 (784·1 to 1484·7) | 1080·5 (763·6 to 1443·3) | 986·6 (685·3 to 1334·1) | −3·1% (−6·7 to 0·6) | −8·7% (−14·8 to −2·8) | −11·5% (−17·5 to −5·6) |
Depressive disorders | 2 | 2 | 2 | 799·5 (550·6 to 1084·7) | 861·6 (586·2 to 1182·1) | 798·7 (549·4 to 1128·5) | 7·8% (0·1 to 15·9) | −7·3% (−15·9 to 2·3) | −0·1% (−7·9 to 7·8) |
Other musculoskeletal disorders | 5 | 3 | 3 | 525·7 (356·8 to 738·5) | 622·8 (426·9 to 862·1) | 639·5 (427·9 to 891·1) | 18·5% (10·3 to 26·7) | 2·7% (−6·9 to 12·2) | 21·6% (10·9 to 32·4) |
Falls | 6 | 6 | 4 | 464·5 (315·3 to 662·1) | 521·9 (359·5 to 737·5) | 564·8 (390·6 to 799·8) | 12·4% (9·8 to 14·9) | 8·2% (6·6 to 9·8) | 21·6% (19·2 to 24·2) |
Anxiety disorders | 4 | 5 | 5 | 548·4 (362·0 to 775·8) | 536·7 (381·0 to 724·2) | 555·3 (366·7 to 785·0) | −2·1% (−18·7 to 19·1) | 3·5% (−13·2 to 23·5) | 1·3% (−5·4 to 9·1) |
Headache disorders | 3 | 4 | 6 | 550·3 (122·6 to 1188·8) | 551·6 (123·3 to 1192·6) | 551·5 (122·4 to 1178·5) | 0·2% (−3·0 to 3·3) | 0·0% (−2·7 to 3·1) | 0·2% (−3·0 to 3·5) |
Exposure to mechanical forces | 8 | 7 | 7 | 445·7 (291·7 to 671·0) | 407·9 (265·1 to 616·0) | 419·4 (274·8 to 638·3) | −8·5% (−9·9 to −6·8) | 2·8% (1·4 to 4·2) | −5·9% (−7·7 to −4·2) |
Drug-use disorders | 12 | 8 | 8 | 303·1 (209·7 to 409·4) | 359·1 (251·9 to 476·2) | 411·5 (288·3 to 547·0) | 18·5% (2·6 to 37·5) | 14·6% (1·8 to 29·3) | 35·8% (19·9 to 55·6) |
Age-related and other hearing loss | 10 | 9 | 9 | 382·3 (265·9 to 542·8) | 355·5 (245·1 to 511·4) | 355·2 (240·5 to 508·3) | −7·0% (−10·8 to −3·3) | −0·1% (−5·0 to 5·4) | −7·1% (−12·4 to −1·7) |
Asthma | 7 | 10 | 10 | 459·3 (305·7 to 657·3) | 334·5 (217·1 to 491·3) | 344·3 (217·4 to 519·0) | −27·2% (−36·6 to −17·7) | 2·9% (−11·1 to 16·4) | −25·0% (−37·8 to −8·9) |
Gynaecological diseases | 11 | 11 | 11 | 332·3 (229·5 to 465·8) | 331·1 (227·3 to 466·1) | 327·9 (226·2 to 463·5) | −0·4% (−3·5 to 3·2) | −0·9% (−4·2 to 2·2) | −1·3% (−4·6 to 2·1) |
Diabetes | 19 | 13 | 12 | 198·7 (133·5 to 275·5) | 302·2 (202·3 to 426·4) | 326·8 (216·3 to 460·7) | 52·1% (36·9 to 69·2) | 8·2% (−0·4 to 18·3) | 64·5% (47·6 to 85·2) |
Oral disorders | 9 | 12 | 13 | 423·2 (272·3 to 618·0) | 308·0 (192·7 to 461·7) | 315·3 (193·6 to 482·2) | −27·2% (−32·2 to −21·5) | 2·4% (−9·2 to 15·6) | −25·5% (−35·4 to −14·7) |
Osteoarthritis | 13 | 14 | 14 | 283·0 (143·0 to 565·8) | 297·7 (152·2 to 590·2) | 312·9 (158·4 to 634·0) | 5·2% (−0·9 to 10·9) | 5·1% (−0·1 to 11·3) | 10·6% (6·9 to 14·5) |
Schizophrenia | 14 | 15 | 15 | 247·5 (186·9 to 298·1) | 247·2 (186·8 to 300·3) | 247·2 (187·5 to 300·3) | −0·1% (−7·1 to 7·0) | 0·0% (−5·7 to 6·3) | −0·1% (−6·3 to 6·0) |
Bipolar disorder | 15 | 16 | 16 | 239·8 (145·4 to 363·5) | 241·8 (147·5 to 370·1) | 242·1 (146·1 to 370·2) | 0·8% (−5·6 to 7·5) | 0·1% (−4·2 to 4·6) | 1·0% (−5·5 to 7·9) |
Eating disorders | 22 | 18 | 17 | 151·5 (93·5 to 228·8) | 209·6 (136·6 to 295·8) | 217·7 (142·6 to 307·4) | 38·3% (17·0 to 67·5) | 3·9% (−3·6 to 11·5) | 43·7% (22·2 to 71·8) |
Chronic obstructive pulmonary disease | 16 | 17 | 18 | 225·3 (178·3 to 263·7) | 222·6 (174·3 to 270·1) | 201·1 (160·5 to 236·1) | −1·2% (−12·7 to 14·0) | −9·7% (−22·2 to 2·0) | −10·7% (−15·2 to −6·3) |
Endocrine, metabolic, blood, and immune disorders | 18 | 19 | 19 | 202·5 (134·6 to 283·2) | 201·3 (136·3 to 283·8) | 200·3 (135·1 to 281·3) | −0·6% (−5·6 to 4·4) | −0·5% (−5·6 to 4·5) | −1·1% (−5·8 to 3·7) |
Other unintentional injuries | 17 | 20 | 20 | 212·5 (135·4 to 317·2) | 187·2 (119·4 to 280·3) | 193·8 (123·5 to 290·1) | −11·9% (−13·8 to −9·7) | 3·5% (1·5 to 5·4) | −8·8% (−10·6 to −6·8) |
Alcohol use disorders | 21 | 21 | 21 | 162·5 (107·5 to 233·6) | 171·5 (113·2 to 241·5) | 183·9 (121·5 to 259·4) | 5·5% (−5·6 to 17·1) | 7·2% (−2·5 to 17·9) | 13·2% (1·4 to 26·2) |
Neonatal disorders | 20 | 22 | 22 | 179·6 (134·5 to 235·3) | 163·0 (122·7 to 213·2) | 158·1 (121·1 to 199·7) | −9·2% (−24·8 to 10·2) | −3·0% (−19·7 to 16·9) | −12·0% (−27·4 to 7·7) |
Other mental disorders | 25 | 23 | 23 | 140·9 (93·4 to 201·2) | 140·9 (93·3 to 200·5) | 140·7 (93·9 to 200·1) | 0·0% (−4·4 to 4·5) | −0·2% (−4·3 to 4·3) | −0·2% (−4·2 to 4·2) |
Psoriasis | 23 | 24 | 24 | 145·4 (103·1 to 191·9) | 139·7 (99·8 to 185·3) | 127·0 (90·1 to 167·3) | −3·9% (−9·0 to 1·8) | −9·1% (−14·4 to −3·9) | −12·6% (−17·5 to −7·4) |
Dermatitis | 26 | 25 | 25 | 122·7 (68·1 to 205·4) | 123·5 (69·1 to 202·0) | 122·6 (68·3 to 201·8) | −0·7% (−5·8 to 5·2) | 0·7% (−4·8 to 7·2) | 0·0% (−5·4 to 5·8) |
Note that causes are ordered by their ranking in 2019. YLDs=years of life lived with disability. UI=uncertainty interval.